Personal diabetes stories and experiences that share real challenges, treatment journeys, lifestyle changes and valuable lessons from people living with diabetes.
The University of Florida has launched a new partnership with Google to enhance AI tools for early detection and treatment of type 1 diabetes, building on its existing research ecosystem and private-sector collaborations. The University of Florida has unveiled a…
Scientists in Shanghai have created an oral probiotic capable of detecting and responding to blood sugar fluctuations, signalling a new move towards adaptive, personalised diabetes treatment. Researchers in Shanghai have developed an oral probiotic designed to detect changes in blood…
Emerging research suggests that personalised nutrition strategies could enhance the success of GLP-1-based weight-loss treatments like Wegovy and Ozempic, particularly for patients who struggle with side effects or inadequate response. Experts advocate for integrating biological, genetic, and dietary insights to…
Research reveals that combining GLP-1 receptor agonists with basal insulin does not significantly increase the likelihood of insulin discontinuation in adults with type 2 diabetes, challenging assumptions about their role in insulin dependency reduction. Adding a GLP-1 drug to basal…
Jake Thompson, a Newfoundland-based puppeteer diagnosed with type 1 diabetes as a child, leverages puppetry and advocacy to influence research funding and raise awareness across Canada, including a notable trip to Parliament Hill. Jake Thompson has turned a childhood fascination…
A new systematic review underscores the critical role of nurse-led interventions in enhancing both clinical and psychosocial outcomes for those with chronic kidney disease, highlighting a shift towards more accessible, patient-centred care. A systematic review and meta-analysis suggests that nurse-led…
As metabolic disorders become more prevalent worldwide, doctors are emphasising early screening for liver problems in people with diabetes to prevent serious complications, with recent research revealing new connections between these conditions. Doctors are paying closer attention to the link…
Rosie O’Donnell reveals her recent health transformation, attributing her improved well-being and weight loss to the diabetes medication Mounjaro, highlighting a growing trend among celebrities openly discussing the impact of GLP-1 therapies. Rosie O’Donnell says she feels better in her…
Recent studies indicate that antibiotics can alter gut bacteria in ways that potentially affect blood sugar regulation, especially in those with existing metabolic conditions, though effects vary and more research is needed. Antibiotics can sometimes do more than clear an…
New research indicates that restoring body mass index to normal levels may slow the progression from preclinical to clinical type 1 diabetes, especially among children and adolescents, highlighting potential preventive strategies. Normalising body mass index was linked to a lower…
New research indicates that different formulations of GLP-1 receptor agonists may offer diverse benefits including blood sugar, blood pressure, and cholesterol improvements, paving the way for tailored treatments beyond obesity management. A new analysis suggests GLP-1 medicines may do more…
A widespread marketing tactic attaches the ‘Glucose Reset Ritual’ to various blood-sugar supplements, employing fake endorsements and shifting brand names, raising concerns over consumer deception and safety. The “Glucose Reset Ritual” is not a single product so much as a…
